Skip to main content

JPMORGAN CHASE & CO

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 19617 NEW YORK, NY

Position in VRDN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$20,730,938
-$10,708,352 QoQ
Shares Held
1,059,864
+4.9% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. VRDN ranks #54 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,730,938 1,059,864
2025-12-31 $31,439,290 1,010,260
2025-09-30 $6,671,089 309,133
2025-06-30 $5,815,525 415,989
2025-03-31 $4,024,452 298,550
2024-12-31 $5,834,082 304,334
2024-09-30 $9,107,984 400,351
2024-06-30 $1,635,485 125,710
2024-03-31 $858,392 49,023
2023-12-31 $1,240,108 56,938
2023-09-30 $781,143 50,922
2023-06-30 $1,426,733 59,972
2023-03-31 $1,256,150 49,377
2022-12-31 $5,034,605 172,359
2022-09-30 $1,420,480 69,258
2022-06-30 $212,180 18,339
2022-03-31 $345,134 18,666
2021-12-31 $257,662 13,033
2021-03-31 $167 10